Insulin pens

Other pens

Novo Nordisk is discontinuing several insulin delivery devices

Effective January 1, 2010, the following insulin delivery devices will no longer be available. If you are currently using any of the products listed below, it’s important to ask your doctor about other options.

• Novolin® R InnoLet® (Regular, Human Insulin Injection [recombinant DNA origin] USP in a 3 mL disposable prefilled insulin syringe)
• Novolin® N InnoLet® (NPH, Human Insulin Isophane Suspension [recombinant DNA origin] in a 3 mL disposable prefilled insulin syringe)
• Novolin® 70/30 InnoLet® (70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection [recombinant DNA origin] USP in a 3 mL disposable prefilled insulin syringe)
• Novolin® R PenFill® 3 mL cartridges (Regular, Human Insulin Isophane Suspension [recombinant DNA origin])
• Novolin® N PenFill® 3 mL cartridges (NPH, Human Insulin Isophane Suspension [recombinant DNA origin])
• Novolin® 70/30 PenFill® 3 mL cartridges (70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection [recombinant DNA origin])


• Please note that only these insulin delivery devices are being discontinued.

If you have any questions about the discontinuation of these products, please call 1-800-727-6500. It’s also a good time to talk to your doctor about alternative Novo Nordisk treatment options – so you can find out which insulin delivery device may be right for you.

Levemir®, NovoLog® and NovoLog® Mix 70/30 are for single patient use only. Patients should not share their FlexPen® with another patient even if needles are changed between patients.

Before using these products, be sure to read important information for use.

PC users: Right-click on the link and choose ‘save target as,’ then choose where to save the information on your PC.

Mac users: Click and hold the link. Choose ‘save link as’ from pop-up menu, then choose where to save the information on your Mac.

NovoPen® 3 Instructions for Use in PDF format (690 KB)

Novolin® N InnoLet® Package Insert in PDF format (450 KB)

Novolin® R InnoLet® Package Insert in PDF format (275 KB)

Novolin® 70/30 InnoLet® Package Insert in PDF format (425 KB)

Indications and Usage:

Levemir® (insulin detemir [rDNA origin] injection) is a man-made long-acting insulin that is used to control high blood sugar in adults and children with diabetes mellitus.

NovoLog® (insulin aspart [rDNA origin] injection) is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus.

NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a man-made insulin that is used to control high blood sugar in adults with diabetes mellitus.

Levemir®
Important Safety Information

Do not take Levemir® if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in Levemir®. If you take too much Levemir® your blood sugar may fall too low.

Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take Levemir®.

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Never mix Levemir® with other insulin products or use in an insulin pump.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your Levemir® dose may change if you take other medicines.

The most common side effect of insulin therapy, including Levemir®, is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

For more information, please see Levemir® complete Prescribing Information

NovoLog®
Important Safety Information

Do not take NovoLog® if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLog®. If you take too much NovoLog® your blood sugar may fall too low.

NovoLog® is a fast-acting insulin. You should eat a meal within 5 to 10 minutes after using NovoLog® to avoid low blood sugar. Do not inject NovoLog® if you do not plan to eat right after using NovoLog®. Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLog®.

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Do not mix NovoLog® with any other insulins when used in a pump or with any insulins other than NPH when used with injections by syringe.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLog® dose may change if you take other medicines.

NovoLog® has not been studied in children with type 2 diabetes or in children with type 1 diabetes under the age of two.

The most common side effect of insulin therapy, including NovoLog®, is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

For more information, please see Novolog® complete Prescribing Information

NovoLog® Mix 70/30
Important Safety Information

Do not use NovoLog® Mix 70/30 if your blood glucose is too low (hypoglycemia) or if you are allergic to anything in NovoLog® Mix 70/30. If you take too much NovoLog® Mix 70/30 your blood sugar may fall too low.

NovoLog® Mix 70/30 is a pre-mixed insulin. You should eat a meal within 15 minutes after using NovoLog® Mix 70/30 to avoid low blood sugar. Do not inject NovoLog® Mix 70/30 if you are not planning to eat within 15 minutes. Check your blood glucose regularly. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLog® Mix 70/30.

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Never mix NovoLog® Mix 70/30 with other insulin products or use it in an insulin pump.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLog® Mix 70/30 dose may change if you take other medicines.

The most common side effect of insulin therapy, including NovoLog® Mix 70/30, is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

For more information, please see Novolog®Mix 70/30 complete Prescribing Information